Detection of minimal residual disease in peripheral blood prior to clinical relapse of childhood acute lymphoblastic leukaemia using PCR.
暂无分享,去创建一个
M. Haber | M. Norris | E. Kwan | G. Marshall | A. Lal
[1] M. Kami,et al. Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood , 1998, The Lancet.
[2] H. Cavé,et al. Clinical Significance of Minimal Residual Disease in Childhood Acute Lymphoblastic Leukemia , 1998 .
[3] A. Morley,et al. Monitoring minimal residual disease in peripheral blood in B‐lineage acute lymphoblastic leukaemia , 1997, British journal of haematology.
[4] D. Johnston,et al. Measurement of residual leukemia during remission in childhood acute lymphoblastic leukemia. , 1997, The New England journal of medicine.
[5] N. Giri,et al. Allogeneic bone marrow transplantation for children with acute lymphoblastic leukemia conditioned with busulfan, cyclophosphamide and melphalan. , 1996, Bone marrow transplantation.
[6] M. Haber,et al. Detection of evolving immunoglobulin heavy-chain gene rearrangements in acute lymphoblastic leukemia: a PCR-based assay employing overlapping DJH primers. , 1995, Leukemia.
[7] A. Morley,et al. Outcome prediction in childhood acute lymphoblastic leukaemia by molecular quantification of residual disease at the end of induction , 1994, The Lancet.
[8] C. Bartram,et al. Use of polymerase chain reactions to monitor minimal residual disease in acute lymphoblastic leukemia patients. , 1991, Blood.